Main
>
ONCOLOGY (**)
>
Endometrial Cancer
>
TREAT.:
>
JP. E. Lenvatinib+PembrolizuMAb
>
(*) CA Approval Date: 2019. 09.17.
(*) CA Approval Date: 2019. 09.17.'s products
This section has no products